secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001932393-24-000054
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare increases quarterly dividend 17% and sets medium-term targets at 2024 Investor Day
--------------------------------------------------------------------------------

- Quarterly cash dividend increased ~17%; no new per-share amount or dates stated in release.
- Medium-term (2026-2028) targets: organic revenue growth 4-6%, adjusted EBIT margin high-teens to 20%+, adjusted EPS growth high-single to low-double digit, FCF conversion 90%+.
- Reiterated 2024 outlook: organic revenue growth 1-2% trending lower end, adjusted EBIT margin 15.8-16.0%, adjusted EPS $4.25-$4.35, FCF ~$1.8B.
- Company highlighted progress since spin-off and precision care strategy focused on AI, radiopharmaceuticals, and enterprise partnerships.
- CEO Peter Arduini expressed confidence in growth pipeline; CFO Jay Saccaro cited margin expansion and disciplined capital allocation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000054/0001932393-24-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000054/gehc-20241121.htm
  HTML page:      https://secwatch.observer/filing/0001932393-24-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer